Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah A Knight

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Science Immunology|May 20, 2018
Tumor immune evasion arises through loss of TNF sensitivityConor J Kearney, Stephin J Vervoort, Simon J Hogg, et al.
Cell Reports|October 21, 2020
Temporal Analysis of Brd4 Displacement in the Control of B Cell Survival, Proliferation, and DifferentiationIsabella Y Kong, Joel S Rimes, Amanda Light, et al.
Science Advances|September 12, 2020
CDK13 cooperates with CDK12 to control global RNA polymerase II processivityZheng Fan, Jennifer R Devlin, Simon J Hogg, et al.
Cell Reports|November 26, 2013
Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitorsMichaela Waibel, Vanessa S Solomon, Deborah A Knight, et al.
Cell|May 18, 2021
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancerStephin J Vervoort, Sarah A Welsh, Jennifer R Devlin, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Science Immunology|May 20, 2018
Tumor immune evasion arises through loss of TNF sensitivityConor J Kearney, Stephin J Vervoort, Simon J Hogg, et al.
Cell Reports|October 21, 2020
Temporal Analysis of Brd4 Displacement in the Control of B Cell Survival, Proliferation, and DifferentiationIsabella Y Kong, Joel S Rimes, Amanda Light, et al.
Science Advances|September 12, 2020
CDK13 cooperates with CDK12 to control global RNA polymerase II processivityZheng Fan, Jennifer R Devlin, Simon J Hogg, et al.
Cell Reports|November 26, 2013
Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitorsMichaela Waibel, Vanessa S Solomon, Deborah A Knight, et al.
Cell|May 18, 2021
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancerStephin J Vervoort, Sarah A Welsh, Jennifer R Devlin, et al.
Pageof 4